Role of Proteomics in the Development of Personalized Medicine
Author:
- 1 January 2016
- book chapter
- Published by Elsevier
- Vol. 102, 41-52
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Stable isotope labelling methods in mass spectrometry-based quantitative proteomicsJournal of Pharmaceutical and Biomedical Analysis, 2015
- Detection of FGF15 in Plasma by Stable Isotope Standards and Capture by Anti-peptide Antibodies and Targeted Mass SpectrometryCell Metabolism, 2015
- Mass Cytometry: A Highly Multiplexed Single-Cell Technology for Advancing Drug DevelopmentDrug Metabolism and Disposition, 2015
- High abundant protein removal from rodent blood for biomarker discoveryBiochemical and Biophysical Research Communications, 2014
- Reverse Phase Protein Arrays: Mapping the Path Towards Personalized MedicineMolecular Diagnosis & Therapy, 2014
- Post-Genomics Nanotechnology Is Gaining Momentum: Nanoproteomics and Applications in Life SciencesOMICS: A Journal of Integrative Biology, 2014
- Pharmaco-proteomics opportunities for individualizing neurovascular treatmentNeurological Research, 2013
- Nanoproteomics enabling personalized nanomedicineAdvanced Drug Delivery Reviews, 2012
- The Lucid Proteomics System for top-down biomarker researchArchives of Physiology and Biochemistry, 2010
- Protein biomarker quantification by mass spectrometryExpert Opinion on Medical Diagnostics, 2009